Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort

Autor: Jonasch, Eric, Bauer, Todd M., Papadopoulos, Kyriakos P., Plimack, Elizabeth R., Merchan, Jaime R., McDermott, David F., Dror Michaelson, M., Appleman, Leonard J., Roy, Ananya, Perini, Rodolfo F., Liu, Yanfang, Choueiri, Toni K.
Zdroj: In European Journal of Cancer January 2024 196
Databáze: ScienceDirect
Externí odkaz: